WallStSmart
TGTX

TG Therapeutics Inc

NASDAQ: TGTX · HEALTHCARE · BIOTECHNOLOGY

$33.58
-2.89% today

Updated 2026-04-29

Market cap
$5.36B
P/E ratio
12.12
P/S ratio
8.70x
EPS (TTM)
$2.77
Dividend yield
52W range
$25 – $46
Volume
2.0M

TG Therapeutics Inc (TGTX) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$11.21M$3.45M$980577.00$1.25M$365662.00$18.64M$15.91M$22.07M$48.11M$86.75M$113.47M$54.78M$97.38M$83.62M$163.01M$625.64M$379.63M$193.57M$329.59M$577.69M
Cash & equivalents
Current assets$11.03M$3.29M$865538.00$874240.00$263725.00$869177.00$9.84M$18.48M$42.30M$85.22M$86.87M$50.86M$93.32M$79.03M$149.15M$611.74M$330.96M$168.27M$317.94M$566.36M
Total liabilities$1.67M$1.94M$1.87M$5.62M$7.15M$24.00M$6.27M$6.52M$48.11M$86.75M$113.47M$54.78M$97.38M$59.58M$124.40M$106.29M$142.48M$134.99M$169.09M$355.33M
Current liabilities$1.67M$1.94M$1.87M$1.49M$2.53M$3.29M$1.61M$2.22M$6.32M$5.12M$10.53M$16.88M$27.96M$38.85M$84.45M$87.55M$65.38M$53.20M$53.72M$90.68M
Long-term debt$1.17M$614000.00$16.13M$4.01M$2.48M$64529.00$0.00$0.00$0.00$0.00$28.97M$7.72M$66.79M$71.14M$100.12M$244.43M
Shareholder equity
Retained earnings$-33.27M$-42.97M$-55.00M$-59.27M$-61.93M$-61.31M$-853074.00$-18.93M$-39.40M$-95.19M$-158.13M$-236.39M$-354.86M$-528.35M$-701.22M$-980.60M$-1.33B$-1.53B$-1.55B$-1.53B
Accounts receivable$244479.00$27169.00$85516.00$186021.00$83852.00$108468.00$95000.00$0.00$1.39M$0.00$51.09M$129.19M
Inventory$4408.00$0.00$0.00$-3.20M$6.09M$-16.04M$5.59M$7.95M$9.69M$-23.60M$0.00$39.82M$110.46M
Goodwill$629752.00$799391.00$799391.00$799391.00$799391.00$799391.00$799391.00$799000.00$799000.00$799000.00$799000.00$799000.00$799000.00$799000.00